Cadila Healthcare reports 41% rise in Q3 consolidated net profit

06 Feb 2021 Evaluate

Cadila Healthcare has reported results for third quarter ended December 31, 2020.

The company has reported a fall of 34.32% in its net profit at Rs 140.30 crore for the quarter under review as compared to Rs 213.60 crore for the same quarter in the previous year. However, total income of the company increased by 11.67% at Rs 1,943.80 crore for Q3FY21 as compared Rs 1,740.70 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported a rise of 41% in its net profit at Rs 527.20 crore for the quarter under review as compared to Rs 373.90 crore for the same quarter in the previous year. Total income of the company increased by 4.51% at Rs 3,823.10 crore for Q3FY21 as compared Rs 3,658.20 crore for the corresponding quarter previous year.

Zydus Lifesciences Share Price

958.90 0.00 (0.00%)
23-Apr-2024 15:41 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1483.75
Dr. Reddys Lab 5947.30
Cipla 1347.70
Zydus Lifesciences 958.90
Lupin 1580.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.